CHRISTOPHER WILSON: Open Payments
NPI 1093886178 · MILL CREEK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 71 payments from 15 companies in 2025. Trend: 2023 $585 · 2024 $1,257 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $309 |
| Vanda Pharmaceuticals Inc. | 10 | $212 |
| Janssen Pharmaceuticals, Inc | 9 | $208 |
| Axsome Therapeutics, Inc. | 6 | $154 |
| Alkermes, Inc. | 6 | $145 |
| ABBVIE INC. | 4 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
Products named: CAPLYTA, FANAPT, Auvelity, ARISTADA, SPRAVATO, VRAYLAR, AUSTEDO XR, REXULTI.
Industry payments across WA — which companies pay providers there.
